Skip to content

The Effect of Ice Cold Mentholated Water Spray After Rhinoplasty

The Effect of Ice-Cold Mentholated Water Spray on Thirst Perception, Dry Mouth, Nausea, and Physiological Parameters in the Post-Rhinoplasty Period

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07233057
Enrollment
90
Registered
2025-11-18
Start date
2025-01-01
Completion date
2025-08-01
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty

Keywords

Ice water spray, Mentholated cold water spray

Brief summary

This clinical trial aims to evaluate the effects of a menthol-infused cold water spray on thirst perception, dry mouth, nausea, and physiological parameters in patients after rhinoplasty. The intervention is expected to provide a refreshing sensation, alleviate discomfort associated with postoperative thirst and dryness, and contribute to improved patient comfort and recovery. Physiological parameters such as heart rate, blood pressure, and oxygen saturation will also be monitored to assess systemic effects.

Interventions

OTHERMenthol Cool Water Spray

Sterile ice water with menthol, cooled between 0-6°C in the refrigerator, will be stored in glass bottles with oral spray heads. The first application will be made half an hour after extubation, and then every hour for the next three hours. The spray will be applied to different areas of the patient's mouth (upper jaw, lower jaw, left cheek, right cheek, and tongue).

OTHERIce water spray

Sterile ice water, cooled to 0-6°C in the refrigerator, will be stored in glass bottles with oral spray heads. The first application will be made half an hour after extubation, and then every hour for the next three hours. The spray will be applied to different areas of the patient's mouth (upper jaw, lower jaw, left cheek, right cheek, and tongue).

Sponsors

Firat University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Must be extubated in the surgical intensive care unit after surgery for at least 3 hours or more * Must be 18 years of age or older * Must be conscious and oriented to time and place * Must be ASA class I-III and Mallampati class I-II, must have a Mann assessment of swallowing ability score of ≥95, and must have a Glasgow Coma Scale (GCS) score of 15 * Must have given informed consent to participate in the study

Exclusion criteria

Patients were excluded from the study if they had: • Ingestion or absolute contraindications to swallowing any substance, * Mandibular trauma, * Patients undergoing ear, nose, and throat, intracranial, or oral surgery, * Patients allergic to menthol or those who do not prefer menthol water, * Patients with compromised oral and lingual mucosal integrity before surgery, * Patients with any neurological, renal, cardiac, or pulmonary disease, * Patients taking psychoactive medications.

Design outcomes

Primary

MeasureTime frameDescription
Severity of dry mouthThe samples were evaluated at 4 time points: immediately before the first application (To) and 30 minutes after each of the three applications (T1, T2, T3).Severity of dry mouth The severity of dry mouth was assessed using a VAS with a score between 0 and 10 (0 = I do not experience dry mouth at all, 10 = I experience very severe dry mouth).
Nausea SeverityThe samples were evaluated at 4 time points: immediately before the first application (To) and 30 minutes after each of the three applications (T1, T2, T3).Nausea is assessed in the same way using the Vas. Nausea is assessed by labeling one end of the scale as no nausea and the other as very severe nausea and asking the patient to place a mark on the scale indicating the severity of nausea. The distance (in cm) from the no nausea end of the scale to the mark made by the patient is used to measure the patient's nausea.
372 / 5.000 Thirst SeverityThe samples were evaluated at 4 time points: immediately before the first application (To) and 30 minutes after each of the three applications (T1, T2, T3).A Visual Analog Scale (VAS) was used to assess the subjects' thirst severity, with a score ranging from 0 to 10 (0 = not at all, 10 = very severe).
Physiological Parameters Tracking FormThe samples were evaluated at 4 time points: immediately before the first application (To) and 30 minutes after each of the three applications (T1, T2, T3).This form was also developed by the researchers and included heart rate, systolic and diastolic blood pressures, and oxygen saturation levels. Participants' physiological parameters were recorded a total of four times in both groups: once at baseline and then 30 minutes after each exercise.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026